Favipiravir

CHEMBL221722 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
157.1 g/mol
LogP
-0.6
Phase
4

This antiviral medication blocks the enzyme that influenza viruses and some other RNA viruses use to copy their genetic material. It has been studied and used for influenza and certain other viral infections in some countries.

Peso molecular

157,1000 g/mol

LogP

-0,60

TPSA

84,60 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NC(=O)c1nc(F)cnc1O

InChI

InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)

Molecular Formula

C5H4FN3O2

HBD / HBA

2 / 4

Enlaces Rotables

1

Átomos Pesados

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This antiviral medication blocks the enzyme that influenza viruses and some other RNA viruses use to copy their genetic material. It has been studied and used for influenza and certain other viral infections in some countries.

Yes, Favipiravir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL221722. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 492405. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.